SCHEMBL6620118

SCHEMBL6620118

NNC(=O)C1=NOc2ccccc2C1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.37
MAOA P21397 1/20 0.37
GAA P10253 3/20 0.35
ALDH1A1 P00352 2/20 0.35
MAPT P10636 2/20 0.35
P2RX7 Q99572 3/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
KDM4E B2RXH2 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MPO P05164 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2A6 P11509 1/20 0.33
CYP2C19 P33261 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA9 Q16790 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1493436 0.83 MAOA (0.39) MAOBMAOAGAAALDH1A1MAPT
SCHEMBL3783560 0.81 MAOA (0.41) MAOBMAOAGAAALDH1A1KDM4E
SCHEMBL10927335 0.81 MAOA (0.41) MAOBMAOAGAAALDH1A1KDM4E
SCHEMBL8482200 0.81 CA12 (0.41) MAOBMAOAGAAALDH1A1MAPT
SCHEMBL8482832 0.74 KMT2A (0.46) ALDH1A1MAPTMEN1KMT2AKDM4E
SCHEMBL8486535 0.73 HSD17B10 (0.40) MAOBMAOAGAAALDH1A1MAPT
SCHEMBL10592012 0.73 MAOA (0.42) MAOBMAOA
SCHEMBL4244976 0.71 AKR1B1 (0.39) MAOBMAOAGAAALDH1A1MAPT
SCHEMBL10718454 0.70 FKBP5 (0.42) MAOBMAOAGAAALDH1A1KDM4E
SCHEMBL584704 0.70 MAOA (0.46) MAOBMAOAGAAALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054673-B1 BENZOXAZINE COMPOUNDS FOR ENHANCING SYNAPTIC RESPONSE UNIV CALIFORNIA (US) 2004-03-10 EP disclosed
EP-1054673-A4 BENZOXAZINE COMPOUNDS FOR ENHANCING SYNAPTIC RESPONSE CORTEX PHARMA INC (US) 2001-07-18 EP disclosed
EP-1054673-A1 BENZOXAZINE COMPOUNDS FOR ENHANCING SYNAPTIC RESPONSE CORTEX PHARMACEUTICALS, INC. (US) 2000-11-29 EP disclosed
US-5985871-A TREATING SUBJECTS SUFFERING FROM IMPAIRED NERVOUS OR INTELLECTUAL FUNCTIONING DUE TO DEFICIENCIES IN THE NUMBER OF EXCITATORY SYNAPSES OR IN THE NUMBER OF AMPA RECEPTORS; USEFUL FOR TREATMENT OF SCHIZOPHRENIA, RELATED PSYCHOSES, AND CORTEX PHARMACEUTICALS, INC. (US) 1999-11-16 US disclosed
WO-1999033469-A1 BENZOXAZINE COMPOUNDS FOR ENHANCING SYNAPTIC RESPONSE CORTEX PHARMACEUTICALS, INC. (US) 1999-07-08 WO disclosed